Dolphin Entertainment, Inc. (NASDAQ:DLPN – Get Free Report)’s stock price was down 0.8% during trading on Monday . The company traded as low as $1.14 and last traded at $1.17. Approximately 33,312 shares traded hands during mid-day trading, a decline of 3% from the average daily volume of 34,503 shares. The stock had previously closed at $1.18.
Dolphin Entertainment Stock Performance
The stock’s 50-day simple moving average is $1.33 and its 200 day simple moving average is $1.73. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.91 and a current ratio of 0.91. The company has a market capitalization of $13.00 million, a PE ratio of -0.64 and a beta of 1.95.
Dolphin Entertainment (NASDAQ:DLPN – Get Free Report) last announced its quarterly earnings data on Wednesday, August 14th. The company reported ($0.16) EPS for the quarter, beating analysts’ consensus estimates of ($0.18) by $0.02. Dolphin Entertainment had a negative net margin of 31.53% and a negative return on equity of 73.80%. The company had revenue of $11.45 million for the quarter.
About Dolphin Entertainment
Dolphin Entertainment, Inc, together with its subsidiaries, operates as an independent entertainment marketing and production company in the United States. The company operates in two segments, Entertainment Publicity, and Marketing and Content Production. The Entertainment Publicity and Marketing segment provides diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic communications, strategic marketing consulting, social media and influencer marketing, digital marketing, creative branding, talent publicity, and entertainment marketing services, as well as produces promotional video content.
See Also
- Five stocks we like better than Dolphin Entertainment
- How to Capture the Benefits of Dividend Increases
- Intel: Is Now the Time to Be Brave?Â
- 3 Fintech Stocks With Good 2021 Prospects
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Dolphin Entertainment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolphin Entertainment and related companies with MarketBeat.com's FREE daily email newsletter.